Quantum Cyber N.V. Cash Flows From Used In Financing Activities
Quantum Cyber N.V. (QUCY) reported Cash Flows From Used In Financing Activities of $2.68 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2025-09-26
- Quantum Cyber N.V. cash flows from used in financing activities for the quarter ending 2023-12-31 was $3.47M.
- Quantum Cyber N.V. cash flows from used in financing activities for the quarter ending 2023-09-30 was $4.57M.
- Quantum Cyber N.V. cash flows from used in financing activities for the quarter ending 2023-06-30 was $5.42M.
- Quantum Cyber N.V. cash flows from used in financing activities for the quarter ending 2023-03-31 was $773.48K, a 96.79% decline year-over-year.
| Period end | Cash Flows From Used In Financing Activities 3 month | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 9 month | Cash Flows From Used In Financing Activities 12 month |
|---|---|---|---|---|
| 2025-06-30 | $2.68M 6-K · filed 2025-09-26 | |||
| 2024-12-31 | $16.60M 20-F · filed 2025-03-31 | |||
| 2024-06-30 | $2.55M 6-K · filed 2025-09-26 | |||
| 2023-12-31 | $3.47M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | $8.03M derived: sum of 2 quarters · filed 2025-03-31 | $13.45M derived: sum of 3 quarters · filed 2025-03-31 | $14.23M 20-F · filed 2025-03-31 |
| 2023-09-30 | $4.57M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | $9.99M derived: sum of 2 quarters · filed 2024-10-18 | $10.76M 6-K · filed 2023-11-16 | $10.65M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | $5.42M derived: 6-K 6 month − 6-K 3 month · filed 2024-10-18 | $6.19M 6-K · filed 2024-10-18 | $6.08M derived: sum of 3 quarters · filed 2025-03-31 | $6.04M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | $773.48K 6-K · filed 2023-05-16 | $663.97K derived: sum of 2 quarters · filed 2025-03-31 | $625.25K derived: sum of 3 quarters · filed 2025-03-31 | $606.41K derived: sum of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | -$109.51K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | -$148.23K derived: sum of 2 quarters · filed 2025-03-31 | -$167.07K derived: sum of 3 quarters · filed 2025-03-31 | $23.94M 20-F · filed 2025-03-31 |
| 2022-09-30 | -$38.72K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | -$57.56K derived: sum of 2 quarters · filed 2023-11-16 | $24.05M 6-K · filed 2023-11-16 | |
| 2022-06-30 | -$18.84K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | $24.09M 6-K · filed 2023-08-15 | ||
| 2022-03-31 | $24.11M 6-K · filed 2023-05-16 | |||
| 2021-12-31 | $10.61M 20-F · filed 2024-04-09 | |||
| 2021-06-30 | $217.03K 6-K · filed 2022-09-07 | |||
| 2020-12-31 | $396.68K 20-F · filed 2023-04-07 | |||
| 2019-12-31 | $424.00K 20-F · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |